These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 27097115)

  • 1. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain.
    Kim WS; Kim JS; Cha SB; Kim H; Kwon KW; Kim SJ; Han SJ; Choi SY; Cho SN; Park JH; Shin SJ
    Oncotarget; 2016 May; 7(18):24962-82. PubMed ID: 27097115
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kim WS; Jung ID; Kim JS; Kim HM; Kwon KW; Park YM; Shin SJ
    Front Cell Infect Microbiol; 2018; 8():95. PubMed ID: 29637049
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Su H; Zhang Z; Liu Z; Peng B; Kong C; Wang H; Zhang Z; Xu Y
    J Biol Chem; 2018 Jun; 293(26):10287-10302. PubMed ID: 29739853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis.
    Kim WS; Kim JS; Kim HM; Kwon KW; Eum SY; Shin SJ
    Sci Rep; 2018 Sep; 8(1):14411. PubMed ID: 30258084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection.
    Kim WS; Kim JS; Cha SB; Kim SJ; Kim H; Kwon KW; Han SJ; Choi SY; Shin SJ
    Immunobiology; 2016 Mar; 221(3):440-53. PubMed ID: 26655143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine efficacy of a
    Kwon KW; Choi HH; Han SJ; Kim JS; Kim WS; Kim H; Kim LH; Kang SM; Park J; Shin SJ
    FASEB J; 2019 May; 33(5):6483-6496. PubMed ID: 30753099
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.
    Choi HG; Kim WS; Back YW; Kim H; Kwon KW; Kim JS; Shin SJ; Kim HJ
    Eur J Immunol; 2015 Jul; 45(7):1957-71. PubMed ID: 25907170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
    Palma C; Schiavoni G; Abalsamo L; Mattei F; Piccaro G; Sanchez M; Fernandez C; Singh M; Gabriele L
    Eur J Immunol; 2013 Sep; 43(9):2386-97. PubMed ID: 23719937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells.
    Kim JS; Kim WS; Choi HG; Jang B; Lee K; Park JH; Kim HJ; Cho SN; Shin SJ
    J Leukoc Biol; 2013 Oct; 94(4):733-49. PubMed ID: 23825389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.
    Roche CM; Smith A; Lindsey DR; Meher A; Schluns K; Arora A; Armitige LY; Jagannath C
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S96-104. PubMed ID: 22082615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPE39 of the
    Choi HH; Kwon KW; Han SJ; Kang SM; Choi E; Kim A; Cho SN; Shin SJ
    J Cell Sci; 2019 Sep; 132(17):. PubMed ID: 31371491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rv0315, a novel immunostimulatory antigen of Mycobacterium tuberculosis, activates dendritic cells and drives Th1 immune responses.
    Byun EH; Kim WS; Shin AR; Kim JS; Whang J; Won CJ; Choi Y; Kim SY; Koh WJ; Kim HJ; Shin SJ
    J Mol Med (Berl); 2012 Mar; 90(3):285-98. PubMed ID: 21993523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis MmsA, a novel immunostimulatory antigen, induces dendritic cell activation and promotes Th1 cell-type immune responses.
    Kim JS; Kim WS; Choi HH; Kim HM; Kwon KW; Han SJ; Cha SB; Cho SN; Koh WJ; Shin SJ
    Cell Immunol; 2015; 298(1-2):115-25. PubMed ID: 26507911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
    Choi HG; Choi S; Back YW; Paik S; Park HS; Kim WS; Kim H; Cha SB; Choi CH; Shin SJ; Kim HJ
    Oncotarget; 2017 Mar; 8(12):19947-19967. PubMed ID: 28193909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis promotes Th17 expansion via regulation of human dendritic cells toward a high CD14 and low IL-12p70 phenotype that reprograms upon exogenous IFN-γ.
    Søndergaard JN; Laursen JM; Rosholm LB; Brix S
    Int Immunol; 2014 Dec; 26(12):705-16. PubMed ID: 25223368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response.
    Su H; Kong C; Zhu L; Huang Q; Luo L; Wang H; Xu Y
    Oncotarget; 2015 Nov; 6(36):38517-37. PubMed ID: 26439698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response.
    Byun EH; Kim WS; Kim JS; Jung ID; Park YM; Kim HJ; Cho SN; Shin SJ
    FASEB J; 2012 Jun; 26(6):2695-711. PubMed ID: 22415304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.
    Chatterjee S; Dwivedi VP; Singh Y; Siddiqui I; Sharma P; Van Kaer L; Chattopadhyay D; Das G
    PLoS Pathog; 2011 Nov; 7(11):e1002378. PubMed ID: 22102818
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Choi S; Choi HG; Shin KW; Back YW; Park HS; Lee JH; Kim HJ
    J Immunol Res; 2018; 2018():3525302. PubMed ID: 29736404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting
    Velasquez LN; Stüve P; Gentilini MV; Swallow M; Bartel J; Lycke NY; Barkan D; Martina M; Lujan HD; Kalay H; van Kooyk Y; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():471. PubMed ID: 29662482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.